4[1]Kochar M,Guthrie R,Triscari J,et al.Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension[J].Am J Hyptertens,1999,12 (8 Pt 1):797 -805.
5[2]Raskin P,Guthrie R,Flack J,et al.The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide[J].J Hum Hypertens,1999,13(10):683-687.
6[4]Myers MG.Suggested guidelines for determining the troughto-peak ratio of antihypertensive drugs[M].Am J Hypertens,1996,9 (10 Pt 2):76S-82S.
7[5]Zannad F,Matzinger A,Larche J.Trough/peak rations of once daily angiotensin converting enzyme inhibitors and calcium antagonists[J].Am J Hypertens,1996,9 (7):633-643.
8[6]Elliott HL,Meredith PA.Trough:peak ratio:clinically useful or practically irrelevant?[J].J Hypertens,1995,13 (3):279-283.
9[7]Coca A,Calvo C,Sobrino J,et al.Once-daily fixed-combination irbesartan 300mg/hydrochlorothiazide 25mg and circadian blood pressure profile in patients with essential hypertension[J].Clin Ther,2003,25 (11):2849-2864.
